Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Genzyme General and Acadia enter drug discovery collaboration

Nov. 3, 1997

Laminin-like peptides available for licensing from NIH

Nov. 3, 1997

Genetic animal model of psychiatric disorders available for licensing

Oct. 30, 1997

Lilly and Chugai enter into combinatorial chemistry collaboration

Oct. 29, 1997

Dyax and Tularik establish drug discovery collaboration

Oct. 28, 1997

Structure of NO-producing enzyme solved

Oct. 28, 1997

Sibia's TBA technology licensed to Neurocrine Biosciences

Oct. 28, 1997

Atlantic's 2-5A improves efficacy of antisense compounds

Oct. 24, 1997

CombiChem/Athena initiate CNS drug discovery collaboration

Oct. 21, 1997

Aurora Biosciences licenses fluorescent technology from the University of California

Oct. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...